Oncternal Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Oncternal Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Oncternal Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Oncternal Therapeutics by Vanguard Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $185k | 140k | 1.32 |
2024-06-30 | $1.1M | 143k | 7.60 |
2024-03-31 | $1.3M | 143k | 9.00 |